# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000035
Filing Date
2025-04-15
Accepted
2025-04-14 20:32:59
Documents
27
Period of Report
2025-04-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | a2025-04x14appendix3h3g2a.htm | 6-K | 25995
2 | EX-99.1 | exhibit991.htm | EX-99.1 | 4694
3 | EX-99.2 | exhibit992.htm | EX-99.2 | 6559
4 | EX-99.3 | exhibit993.htm | EX-99.3 | 6644
5 | EX-99.4 | exhibit994.htm | EX-99.4 | 7713
6 |  | exhibit991001.jpg | GRAPHIC | 75699
7 |  | exhibit991002.jpg | GRAPHIC | 53368
8 |  | exhibit991003.jpg | GRAPHIC | 72565
9 |  | exhibit991004.jpg | GRAPHIC | 115823
10 |  | exhibit992001.jpg | GRAPHIC | 73191
11 |  | exhibit992002.jpg | GRAPHIC | 59681
12 |  | exhibit992003.jpg | GRAPHIC | 60663
13 |  | exhibit992004.jpg | GRAPHIC | 140727
14 |  | exhibit992005.jpg | GRAPHIC | 95215
15 |  | exhibit993001.jpg | GRAPHIC | 75711
16 |  | exhibit993002.jpg | GRAPHIC | 59677
17 |  | exhibit993003.jpg | GRAPHIC | 57217
18 |  | exhibit993004.jpg | GRAPHIC | 109792
19 |  | exhibit993005.jpg | GRAPHIC | 95321
20 |  | exhibit993006.jpg | GRAPHIC | 53926
21 |  | exhibit994001.jpg | GRAPHIC | 73173
22 |  | exhibit994002.jpg | GRAPHIC | 57355
23 |  | exhibit994003.jpg | GRAPHIC | 53589
24 |  | exhibit994004.jpg | GRAPHIC | 115385
25 |  | exhibit994005.jpg | GRAPHIC | 83885
26 |  | exhibit994006.jpg | GRAPHIC | 92985
27 |  | exhibit994007.jpg | GRAPHIC | 50444
| Complete submission text file | 0001345099-25-000035.txt |  | 2429794

Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25837324
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)